It Seems ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) Will Go Up. Just Reported Less Shorted Shares

June 16, 2018 - By Kurt Siggers

The stock of ACURA PHARMACEUTICALS INC (OTCMKTS:ACUR) registered a decrease of 2.87% in short interest. ACUR’s total short interest was 20,300 shares in June as published by FINRA. Its down 2.87% from 20,900 shares, reported previously. With 17,800 shares average volume, it will take short sellers 1 days to cover their ACUR’s short positions. The short interest to ACURA PHARMACEUTICALS INC’s float is 0.28%.

The stock increased 4.74% or $0.0185 during the last trading session, reaching $0.4085. About 5,993 shares traded. Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. The company has market cap of $8.59 million. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. It currently has negative earnings. The firm has six additional opioid products in various stages of formulation development.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.